Pulmonary alveolar proteinosis and GMSCF antibodies: a case series

H. Bell, K. Nakata, E. Gabbay, Q. Summers, F. Lake (Perth, Australia; Tokyo, Japan)

Source: Annual Congress 2004 - Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Session: Lung fibrosis sarcoidosis alveolar microlithiasis and proteinosis
Session type: Poster Discussion
Number: 4089
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Bell, K. Nakata, E. Gabbay, Q. Summers, F. Lake (Perth, Australia; Tokyo, Japan). Pulmonary alveolar proteinosis and GMSCF antibodies: a case series. Eur Respir J 2004; 24: Suppl. 48, 4089

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary alveolar proteinosis: report of two cases
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009


Pulmonary alveolar proteinosis and GM/CSF antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 30s
Year: 2005

Pulmonary alveolar proteinosis
Source: Eur Respir Rev 2011; 20: 98-107
Year: 2011



Pulmonary alveolar proteinosis
Source: Eur Respir Mon; 2009: 46: 208–224
Year: 2009

Pulmonary alveolar proteinosis, study of 29 cases
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Our cases with pulmonary alveolar proteinosis
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Pulmonary alveolar proteinosis: from classification to therapy
Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020
Year: 2020



Pulmonary alveolar proteinosis: A case report
Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms
Year: 2013

Lung cysts in pulmonary alveolar proteinosis.
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Pulmonary alveolar microlithiasis: case report
Source: Eur Respir J 2004; 24: Suppl. 48, 670s
Year: 2004

Pulmonary alveolar proteinosis
Source: Respipedia Article
Year: 2017

Pulmonary alveolar microlithiasis: a case report
Source: Eur Respir J 2004; 24: Suppl. 48, 489s
Year: 2004

Pulmonary alveolar proteinosis therapy success with combined lavage procedures: a case report
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009


Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report
Source: Eur Respir J 2003; 22: Suppl. 45, 44s
Year: 2003

Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019



PAS-negative pulmonary alveolar proteinosis
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008

Secondary pulmonary alveolar proteinosis after lung transplantation: a single-centre series
Source: Eur Respir J , 49 (2) 1601369; DOI: 10.1183/13993003.01369-2016
Year: 2017


Surfactant proteins in pulmonary alveolar proteinosis in adults
Source: Eur Respir J 2004; 24: 426-435
Year: 2004